Project Grant R34HL175017
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$178K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Washington, DC, USA
Similar Awards
This federal Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) is providing $940,798 to The Miriam Hospital to develop an optimized, stepped care intervention to help under-resourced patients maintain improvements in key health behaviors after completing cardiac rehabilitation. The project will utilize a sequential, multiple assignment, randomized trial (SMART) design to create an adaptive intervention that minimizes patient burden....
This $117,750 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a study investigating the prospective associations between neighborhood environment features and physical activity, as well as weight status, across different age groups. The study will leverage data from five existing NIH-funded studies to efficiently examine long-term impacts over 5-15 year periods. Key objectives include...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is funding a randomized controlled trial to evaluate the effectiveness of gamification and social incentives in increasing adherence to physical activity recommendations among patients with heart failure with preserved ejection fraction (HFPEF). The 5-year, $809,029 award will support a 3-arm trial to assess whether interventions using...
This federal Project Grant award of $116,748.00, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to enhance the recipient's capability as a leader in patient-oriented cardiovascular research and mentorship at Washington University. The key products and services to be delivered under this grant include: 1) Conducting new advanced implementation research using the NHLBI-funded Hypertension Treatment in Nigeria...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA Program 93.837 - Cardiovascular Diseases Research, provides $708,678 to Wake Forest University Health Sciences to conduct a Sequential Multiple Assignment Randomized Trial (SMART). The study aims to determine the most effective interventions to reduce food insecurity and improve adherence to hypertension treatment among patients with uncontrolled hypertension and food insecurity. The...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), will support a $198,936 research project conducted by New York University School of Medicine. The project aims to investigate the impact of restrictive drug coverage policies, such as cost-sharing and prior authorization requirements, on prescribing patterns, medication adherence, and clinical outcomes for patients with heart failure with...
This Project Grant award of $777,954 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a mixed-method study to assess the impact of school environment attributes on adolescent cardiovascular risk and maternal morbidity. The primary objectives are to: 1) create a school-based adolescent preconception cohort by linking school environment, adolescent health, and Medicaid birth data; 2) engage adolescents and...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $422,894 to Miami University to investigate the interactive effects of cardiorespiratory fitness and adiposity on the recovery of impaired glucose control and vascular function following a period of reduced physical activity. The research aims to: 1) examine how existing health status impacts the recovery of impaired glucose control after...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $162,000 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Connecticut. The grant will fund a 12-week proof-of-concept study testing a technology-delivered mindful walking intervention to reduce stress, increase physical activity, and lower blood pressure in Black women with hypertension. The project aims to address disparities in hypertension and physical activity rates among...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports a $498,129 research project to evaluate the implementation of a heart failure "polypill" in India. The primary objectives are to: Conduct formative research to guide development of the polypill strategy, which combines guideline-directed medications for heart failure management. Evaluate whether the polypill implementation strategy reduces cardiovascular...